Integra LifeSciences (NASDAQ:IART – Get Rating) updated its second quarter 2023 earnings guidance on Thursday. The company provided EPS guidance of $0.75-$0.79 for the period, compared to the consensus EPS estimate of $0.85. The company issued revenue guidance of $396.00 million-$400.00 million, compared to the consensus revenue estimate of $404.78 million. Integra LifeSciences also updated […]
Integra LifeSciences (NASDAQ:IART – Get Rating) issued an update on its second quarter 2023 earnings guidance on Thursday morning. The company provided earnings per share guidance of $0.75-$0.79 for the period, compared to the consensus earnings per share estimate of $0.85. The company issued revenue guidance of $396.00 million-$400.00 million, compared to the consensus revenue […]
Integra LifeSciences (NASDAQ:IART – Get Rating) issued an update on its second quarter 2023 earnings guidance on Thursday morning. The company provided EPS guidance of $0.75-$0.79 for the period, compared to the consensus EPS estimate of $0.85. The company issued revenue guidance of $396.00 million-$400.00 million, compared to the consensus revenue estimate of $404.78 million. […]
Integra LifeSciences (NASDAQ:IART – Get Rating) had its price objective lowered by JMP Securities from $75.00 to $65.00 in a report published on Thursday, The Fly reports. A number of other brokerages also recently weighed in on IART. Citigroup reduced their target price on Integra LifeSciences from $60.00 to $59.00 and set a neutral rating […]
Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) – Investment analysts at Oppenheimer decreased their Q2 2023 earnings estimates for shares of Integra LifeSciences in a report issued on Thursday, April 27th. Oppenheimer analyst S. Lichtman now forecasts that the life sciences company will earn $0.78 per share for the quarter, down from their prior […]